Quantification of EGFR mutations in primary and metastatic tumors in non-small cell lung cancer

BACKGROUND: EGFR mutation detection has been widely applied in the prediction of TKIs therapy in Non-Small Cell Lung Cancer (NSCLC). Metastatic tumors rather than primary tumors were usually assayed for those patients in advanced stages. Although the difference of EGFR mutation status in primary and...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Bing, Yang, Ke, Zhao, Jiuzhou, Chang, Yuxi, Ma, Zihui, Dong, Bing, Guo, Yongjun, Ma, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3892091/
https://www.ncbi.nlm.nih.gov/pubmed/24398248
http://dx.doi.org/10.1186/1756-9966-33-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3892091/
https://www.ncbi.nlm.nih.gov/pubmed/24398248
http://dx.doi.org/10.1186/1756-9966-33-5

Ejemplares similares